Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

The surface of Earth is finite. We can measure it. If it was expanding, then its size would grow with time. And once again, good ol' Earth helps us understand what the universe might be doing beyond ...

Despite the odds being stacked against it and a rough launch, 'Halo Infinite' grew into its own good thing over time. Reading time 3 minutes On December 8, 2021, 343 Industries released Halo Infinite.

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

GameSpot may get a commission from retail offers. The time of Halo: Infinite is coming to a close. Microsoft and Halo Studios have revealed that the game's next major update, Operation: Infinite, will ...

This month’s content update for Halo Infinite is its last, as the team focuses on ‘multiple’ Halo titles in development. This month’s content update for Halo Infinite is its last, as the team focuses ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Iconic hip-hop duo Mobb Deep returns with their highly anticipated album Infinite, out today on all streaming platforms via Mass Appeal Records. This marks the first full-length release since the ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...